NDC 85237-1829-04 - Alka-Seltzer Original
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1829
- Requested NDC
- 85237-1829-04
- Package NDCs from labels
- 85237-1829-1, 85237-1829-0, 85237-1829-2, 85237-1829-3, 85237-1829-4, 85237-1829-6, 85237-1829-7, 85237-1829-04
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alka-Seltzer Original - Select Consumer Group | Select Consumer Group | 2026-05-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1829-1 | Alka-Seltzer Original | 1 in 1 BLISTER PACK | TABLET, EFFERVESCENT | 1 | 1 | |
| 85237-1829-1 | Alka-Seltzer Original | 2 in 1 POUCH | TABLET, EFFERVESCENT | 2 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce | 2017-11-01 | Warnings | 8MDF5V39QO |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Richmond Pharmaceuticals, Inc | 236a5672-556a-4d8f-9bb6-5877e363e747 | 2017-10-30 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Richmond Pharmaceuticals, Inc. | 31e76aff-63f6-4ee6-8a48-80a73890e607 | 2017-10-30 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Richmond Pharmaceuticals, Inc. | 6a4c897d-c2a8-41b8-98b7-e7da8e2819ec | 2017-10-30 | Warnings | R16CO5Y76E |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | fa10d93d-b3ed-4675-a117-f573d9e72bca | 2017-10-30 | Warnings | 8MDF5V39QO |
| Aspirin | ASPIRIN | Advance Pharmaceutical Inc. | f2e7332a-bcd6-4aef-9e4c-a2cef5ea9464 | 2017-10-30 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Advance Pharmaceutical Inc. | 8977b821-2843-4436-bd3b-bb902a4b787e | 2017-10-30 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Advance Pharmaceutical Inc. | 968afa79-eaae-4cd9-ba0d-3b5eaa466b58 | 2017-10-30 | Warnings | R16CO5Y76E |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | e9698a4f-1a95-4f28-a945-e8009d1d6dd4 | 2017-09-27 | Warnings, Adverse reactions | 8MDF5V39QO |
| SED-MAX | ACETAMINOPHEN 500 MG WITH CAFFEINE 65MG | Command Brands, LLC | 4920a0e9-6f88-4df0-8657-77c95a3b9617 | 2017-01-19 | Warnings | M013 |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.